ManBetX万博手机网站-唯一官方下载

News

Founder of Surio Therapeutics, Dr. Cheng Jianjun is appointed to Dean of School of Engineering and Chair Professor of Materials Science and Engineering, Westlake University on Aug. 2nd, 2021

· Dean Jianjun Cheng
Chair Professor of Materials Science and Engineering
· 1993 B.S. in Chemistry at Nankai University
· 1996 M.S.in Chemistry at Southern Illinois University at Carbondale
· 2001 Ph.D. degree in Materials Science at the University of California, Santa Barbara
· 2001~2004 Senior Scientist at Insert Therapeutics, Inc.
· 2004 Postdoctoral Research Scientist at MIT
· 2005 Assistant Professor in University of Illinois at Urbana-Champaign (UIUC)
· 2011 Associate Professor in University of Illinois at Urbana-Champaign (UIUC)
· 2015 Full Professor in University of Illinois at Urbana-Champaign (UIUC)
· 2016~2021 Hans Thurnauer Professor of Materials Science and Engineering, UIUC
· 2021 Chair Professor of Materials Science and Engineering,Dean of School of Engineering
· Professor Jianjun Cheng developed IT-101 drug delivery technology at Insert Therapeutics. He also developed aptamer-polylactide nanoparticle delivery system for targeted cancer therapy. These two technologies later entered Phase II clinical trial. At UIUC, his group developed drug-initiated polymerization for PLA-drug nanoparticle formulation, chain-shattering polymeric therapeutics, helical charged polypeptides for gene and siRNA delivery, cell membrane penetration and antimicrobial applications, cell-labeling technology for in vivo cancer targeting and hindered urea dynamic chemistry for self-healing application. He has 41 issued patents, half of which being licensed or being in active use. He has over 200 publications with citation of 20,000.

 

Copyright © 2012-2022 Surio Therapeutics Co., LTD. All rights reserved 备ICP prepared19032322number

XML 地图